Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation

Characteristics of anemia in heart failure: iron metabolism, erythropoietic activity and markers of inflammation

Aim. To determine the characteristics of erythrocyte parameters, iron metabolism, erythropoiesis, inflammation markers in patients with heart failure (CHF) and anemia.Material and methods. The study included 68 patients with HF to describe the characteristics of anemia (general group). Patients of t...

Full description

Bibliographic Details
Main Authors:	A. A. Gurkina, N. I. Stuklov, N. D. Kisly, R. R. Gimadiev, M. S. Kovalchuk
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2023-02-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	хроническая сердечная недостаточность анемия железодефицитные синдромы ферритин эритропоэтин гепцидин
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3332

Similar Items

Anaemia and chronic heart failure
by: T. A. Kazantseva, et al.
Published: (2010-08-01)

CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA
by: M. V. Melnik, et al.
Published: (2015-12-01)

Anemia – an independent risk factor of adverse cardiovascular outcomes in women
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

Renal function in patients with anemia and severe chronic heart failure: effects of iron medications
by: M. A. Efremovtseva, et al.
Published: (2008-08-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ И АНЕМИЯ: РОЛЬ ДЕФИЦИТА ЖЕЛЕЗА И ЕГО КОРРЕКЦИЯ
by: А. М. Шилов, et al.
Published: (2012-02-01)

Resolution of the expert council “Relevant issues of iron deficiency in the Russian Federation”
by: O. M. Drapkina, et al.
Published: (2020-11-01)

CLINICAL FEATURES OF HEART FAILURE WITH LOW EJECTION FRACTION COMBINED WITH ANEMIA
by: Konstantin Viktorovich Protasov, et al.
Published: (2023-09-01)

PROTEINS-REGULATORS OF IRON METABOLISM IN THE DIFFERENTIAL DIAGNOSIS OF IRON-DEFICIENCY ANEMIA
by: Галина Северьевна Суржикова, et al.
Published: (2022-08-01)

Zhelezodefitsitnye sostoyaniya pri beremennosti
by: A V Murashko, et al.
Published: (2004-06-01)

NEW METHOD OF PREVENTION OF IRONDEFENSE ANEMIA IN PREGNANT TEENS
by: E. S. Mikhaylin, et al.
Published: (2018-03-01)

FEATURES OF REGULATION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5D
by: E. S. Lapina, et al.
Published: (2016-03-01)

Etiological structure of anemia in HIV-infected children
by: T. A. Daminov, et al.
Published: (2019-07-01)

APPLICATION OF ERITROPOETINS IN THE COMBINATION WITH INTRAVENOUS PREPARATIONS OF IRON AT CHEMIOINDUCED ANEMIA IN ONCOLOGY
by: L. N. Kudryashova
Published: (2017-01-01)

Biopharmaceuticals in oncology: new horizons, but old problems
by: V. V. Breder
Published: (2022-11-01)

Anemia in renal allograft recipients
by: V. A. Goryainov, et al.
Published: (2018-08-01)

Erythropoiesis and Iron Exchange in Burns
by: E. N. Barkova, et al.
Published: (2007-02-01)

The magnetic-laser therapy in the system treatment of anemia in pregnant women infected with Helicobacter pylori
by: I. V. Aristova, et al.
Published: (2010-02-01)

Current approaches to diagnosing iron-deficiency anemia in children
by: E. A. Balashova, et al.
Published: (2016-03-01)

Echocardiographic characteristics of patients with ischemic and non-ischemic chronic heart failure with reduced ejection fraction
by: N. N. Ilov, et al.
Published: (2022-10-01)

Eritropoetiny v onkologii:pokazaniya k primeneniyu i problemy
by: N S Besova
Published: (2009-12-01)

The informativity of the markers of iron metabolism in the differential diagnosis of anemia of inflammation in children with chronic HBV infection
by: F. I. Inoyatova, et al.
Published: (2021-01-01)

NEW OPPORTUNITIES FOR PREVENTIVE THERAPY WITH STATINS DURING CHD PATIENTS’ REHABILITATION, WITH CLINICAL SIGNS OF MODERATE CHF: EFFECTIVENESS OF ROSUVASTATIN AND EZETIMIBE
by: N. I. Tarasov, et al.
Published: (2016-06-01)

Levels of angiogenesis markers in patients with different heart failure phenotypes
by: R. N. Shepel, et al.
Published: (2022-03-01)

EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE
by: V. N. Larina, et al.
Published: (2016-01-01)

Preoperative Preparation of Patients with Anemia before Shoulder Replacement
by: S. V. Sokolov, et al.
Published: (2021-07-01)

Research of the level of erythropoietin and hypoxia-inducible factor 1-alpha in the blood of children and adolescents with anemia at stage C1–5 of chronic kidney disease
by: E. V. Leonteva, et al.
Published: (2020-03-01)

Lechenie zhelezodefitsitnoy anemii u bol'nykh s miomoy matki
by: V A Burlev, et al.
Published: (2003-08-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01)

DIFFICULTIES OF DIAGNOSTICS OF «COMPETITIVE» PROCESSES: THE SYSTEMIC LUPUS ERYTHEMATOSUS AT THE PATIENT WITH THE MODERN COMORBIDITY. THE CLINICAL CASE
by: D. Y. Kostenko, et al.
Published: (2018-06-01)

Lechenie anemii v onkologii: rol' novogo stimulyatora eritropoeza Aranesp (darbepoetin al'fa)
by: L G Babicheva, et al.
Published: (2007-09-01)

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Фармакоэкономический анализ применения левосимендана у больных с тяжёлой декомпенсированной хронической сердечной недостаточностью
Published: (2018-06-01)

KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY
by: Yu. V. Stavtseva, et al.
Published: (2015-09-01)

Physical training – modulator of peripheral factors for chronic heart failure development
by: A. S. Noskova, et al.
Published: (2007-02-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE
by: N. Yu Borovkova, et al.
Published: (2016-12-01)

ВЛИЯНИЕ АПОПТОЗА НА ТЕЧЕНИЕ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: Ye. N. Berezikova, et al.
Published: (2015-10-01)